Genomix Conference 2023: A Premier Online Event Showcasing the Latest Advancements in Genomics

Cambridge, June 30, 2023 – Claritas Genomics Laboratory is thrilled to announce the highly anticipated Genomix Conference 2023, an exceptional online event set to take place from September 1 to September 3, 2023. This groundbreaking conference is designed to convene esteemed experts, distinguished researchers, and industry professionals from across the globe, fostering collaboration and knowledge…

Read More

Claritas Genomics Laboratory Implements State-of-the-Art Fluidigm Biomark High-Performance PCR System

Cambridge, June 6, 2023 – Claritas Genomics Laboratory, a leading provider of genetic testing and diagnostics, proudly announces the integration of the advanced Fluidigm Biomark high-performance PCR system into its state-of-the-art facility. This cutting-edge technology is set to revolutionize genetic diagnostics and further enhance Claritas Genomics’ precision in identifying and analyzing genetic disorders. Fluidigm Biomark:…

Read More

A Tool Unveiling the Mechanism Behind COVID-19 Susceptibility and Beyond

Researchers at the Wellcome Sanger Institute, in collaboration with partners in Japan and Tel Aviv University, have developed a groundbreaking tool called GASPACHO (GAuSsian Processes for Association mapping leveraging Cell HeterOgeneity). This innovative tool aims to investigate the susceptibility to COVID-19 by capturing dynamic changes in gene expression during the innate immune response. Through GASPACHO,…

Read More

New Research Reveals Insights into Kidney Metabolic Processes

Overview of the study’s focus on genetic studies of paired plasma and urine metabolomes A recent study conducted by scientists at the University of Freiburg sheds light on the genetic underpinnings of metabolic processes in the kidneys. The researchers, from the Institute of Genetic Epidemiology at the Medical Center, examined metabolites in blood and urine…

Read More

Genetic Resilience to Early Onset Alzheimer’s Disease

Uncovering Resilience in the Face of Alzheimer’s A recent NIH-funded case study published in Nature Medicine has revealed groundbreaking findings regarding extreme resilience to a rare genetic form of early-onset Alzheimer’s disease. Biomedical breakthroughs often require extensive research with large sample sizes. Nevertheless, this study demonstrates how studying remarkable individuals can lead to fascinating discoveries…

Read More

New CRISPR-based Gene Editing Technique to Study Cancer Mutations

Researchers at the Massachusetts Institute of Technology (MIT) have developed a new CRISPR-based gene-editing technique to study different unknown cancer mutations. The technique enables researchers to engineer specific cancer-linked mutations into the mouse models, which can help identify and test new drugs that target those mutations. The New CRISPR-based Gene Editing Technique The CRISPR-based gene-editing…

Read More

Genetic Analysis of Chornobyl Dogs

A recent study conducted by scientists has shed light on the genetic differences between the dogs living within the exclusion zone around the Chornobyl Nuclear Power Plant. The study aimed to investigate the impact of low-dose radiation on the animal genomes within the affected area. Genetic Analysis of Dogs The research team collected blood samples…

Read More

Genes and Addiction Disorders

Drug and alcohol addiction is a major public health issue affecting millions of people worldwide. Despite numerous efforts to combat substance abuse, there is still a lack of effective prevention and treatment options available. However, a recent study published in Nature Mental Health has identified genetic markers that could pave the way for more personalized…

Read More